Industry/ Innovation/ Related News

November 2017 – Rutgers University (USA) Received ‘2017 Edison Patent Award’ for Polymer used to develop world’s first fully resorbable, X-Ray visible stent. Dr. Joachim Kohn’s “Biocompatible Polymers for Medical Devices” Invention Received Award from R&D Council of New Jersey in Biomaterials Category.

November 2017 – 480 Biomedical, a clinical-stage life science company, announced a publication in Nature Materials highlighting the novel mechanical properties of the company’s fully bioresorbable polymeric implant technology. Nature Materials, the 480 Biomedical implant has been demonstrated to possess resistive strength similar to metal, while maintaining flexibility and ultimately fully resorbing. This unique combination of attributes is achieved by combining a PLGA base structure with a proprietary bioresorbable elastomer that is cross-linked via an innovative processing method. The elastomer is resistant to stress relaxation, allowing the implant to continually “spring-back”, thereby preventing migration or dislodgement after placement within the body.

November 2017 – Xeltis, which is working on polymer-based heart valve replacement, raised a €45 million ($52 million) investment in an oversubscribed series C round. Xeltis’ bioresorbable, polymer-based technology is designed to allow for the natural restoration of heart valve function via endogenous tissue restoration (ETR). After Xeltis’ valve is implanted, the body develops tissue inside and around the device, forming a natural and fully functional valve within it, the company says. As the new valve heals, the implant is gradually absorbed into the body. The funds will bankroll the continuation of clinical activities, as well as ramp up product and market development for Xeltis’ aortic and pulmonary valve programs, according to a statement. It was the largest investment round for a private medical device company in Europe so far this year.

Get a Sample of This Report @ https://www.marketresearchfuture.com/sample_request/969

Bioresorbable Polymers Market - Segments

Global Bioresorbable Polymers Market is segmented in to 3 Key dynamics for an easy grasp and enhanced understanding.

Segmentation By Types : Comprises - Polysaccharides, Proteins, Polylactic Acid, Polyglycolic Acid and Polycaprolactone.

Segmentation By Application : Comprises - Drug Delivery and Orthopedics.

Segmentation by Regions : Comprises Geographical regions - North America, Europe, APAC and Rest of the World.

Bioresorbable Polymers Market appears to be highly competitive but consolidated. Many large and small key players operating in the market are churning the competition to gain competitive advantage. To sustain their market position these players incorporate acquisition, collaboration, partnership, expansion, and technology launch.

Bioresorbable Polymers are gaining a huge traction over the past decade, owing to its augmented use in the Controlled drug delivery matrix. Consecutively, the global Bioresorbable Polymers Market is exponentially gaining momentum attributed to the burgeoning Healthcare sector. Nowadays, people are inclined towards avoiding surgeries as long as possible and instead prefer controlled drug delivery matrix. Implants made from Bioresorbable Polymers don’t need another operation to take implants out. Bioresorbable Polymers get completely biodegraded in the human body without causing any harm minimizing post-surgery risk to the patient and thus eradicating the need for a second surgery to take off temporary implants.